Ranbaxy Laboratories Ltd’s share price up, gets U.S. regulatory approval for generic version of Novartis’ Diovan
June 27, 2014 11:52 am
Ranbaxy Laboratories Ltd rose in Mumbai trading after it managed to get the approval of the U.S. to start manufacturing a generic version of the blood pressure drug Diovan that is originally made by Novartis AG. This happens about two years after the 3.5-billion-dollar patent protection of the medicine was lost. In May, Mr. Arun […] Read more